 |
|
| Blog results | Results 1 - 10 of about 12,030 for protease inhibitors. (0.49 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Drug Discovery Opinion - DDO Limited - Consultancy for Biotech and ... - http://drugdiscoveryopinion.com/ | |
| 16 Nov 2009 by ACTIONS TRAITEMENTS Several trials of protease inhibitor therapy have produced long-lasting viral suppression statistically non-inferior to two-class therapy. Most successful trials have switched patients to PI monotherapy as a maintenance regimen after ... Actions Traitements - http://www.actions-traitements.org/ [ More results from Actions Traitements ] |
| 17 hours ago by salud equitativa Prescribers should consult the full prescribing information and clinical study information of these protease inhibitors if they are co-administered with a reduced dose of ritonavir. The complete revised labeling will be available at ... CIENCIASMEDICASNEWS - http://elbiruniblogspotcom.blogspot.com/ [ More results from CIENCIASMEDICASNEWS ] |
| 22 Nov 2009 by Alfie Precancerous anal lesions may be very common in some populations: protease inhibitor therapy may help. Posted on 22 November 2009 - 17:54 by Alfie. Share/Bookmark. VN:F [1.6.9_936]. please wait... Rating: 0.0/5 (0 votes cast) ... Life Sciences Blog - http://www.lsblog.org/blog/?p=7247&cpage=1 |
| 5 Nov 2009 by John S James "A course of hepatitis C (HCV) combination therapy including the experimental HCV protease inhibitor telaprevir (VX-950) has produced a sustained viral response (SVR) in over 80% of treatment-naïve, hepatitis C-mono-infected patients ... AIDS Treatment News - http://aidsnews.blogspot.com/ [ More results from AIDS Treatment News ] |
| 21 Nov 2009 by Alfie Precancerous anal lesions may be very common in some populations: protease inhibitor therapy may help. Posted on 21 November 2009 - 20:37 by Alfie. Share/Bookmark · GD Star Rating a WordPress rating system ... Life Sciences Blog - http://www.lsblog.org/blog/ - References |
| 9 Nov 2009 by Maureen Martino Concert Pharmaceuticals Initiates Phase 1b Clinical Trial of CTP-518, Protease Inhibitor for Treatment of HIVConcert Earns $12 Million Milestone from GlaxoSmithKlineCTP-518 has Potential as Unboosted ... Read more... Press Releases - http://www.fiercebiotech.com/press-releases |
| 20 Nov 2009 by Vincent Racaniello Protease inhibitors against HIV have only weak activity against other retroviruses. Even though the catalytic site is relatively similar (they are aspartic proteases with relatively conserved active sites), the flaps of the enzyme are ... virology blog - http://www.virology.ws/ - References |
| 21 hours ago Entry inhibitors will be the next class of anti-HIV drug to arrive on the market, joining the protease inhibitors and reverse transcriptase inhibitors now available. Entry inhibitors, which must be injected, work earlier in the ... Mens Health | Mens Health Supplements |... - http://www.theherbalpills.com/mens-health/ |
| 18 Nov 2009 by Rudack, C., Sachse, F., Albert, N., Becker,... Inhibition of cytokine synthesis was performed using a glucocorticoid, a serine protease inhibitor, and a cysteine protease inhibitor. Finally, signal transduction pathways were analyzed by quantifying phosphorylated forms of MAPKs ... The Journal of Immunology current issue - http://www.jimmunol.org/ |
| 2 Nov 2009 Potential for Rapid and Prolonged Therapeutic Benefit in HCV through Protein Silencing of NS3 Protease Nov 2, 2009 - Avila Therapeutics , Inc., a biotechnology. Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html [ More results from Drugs.com - Clinical Trials ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
